semaglutide 1.5 5mg — Selective GLP-1 Receptor Agonist — Research Peptide – Prime Labs Semaglutide / Cyanocobalamin Injection |

"Thyroid Papillary Microcarcinoma: Etiology, Clinical Manifestations, Diagnosis, Follow-up, Histopathology and Prognosis"

For those using tirzepatide, understanding the dosing for weight loss in units allows for more granular control

Our study included these subgroups and found a higher risk of psychiatric outcomes with semaglutide use

Read the study here

Individuals were started on semaglutide in the time period between November 2021 and November 2022, with no more patients initiated on semaglutide afterward due to its supply shortages

Public Health Dialogue : Theres an ongoing conversation about the balance between drug innovation and patient safety, especially concerning off-label drug use lawsuits where drugs like Ozempic are used for weight loss beyond their primary indication